Comprehensive treatment with Chinese medicine in patients with advanced non-small cell lung cancer: A multicenter, prospective, cohort study

Author:

Liu Jie,Lin Hong-sheng,Hou Wei,Hua Bao-jin,Zhang Pei-tong,Li Jie,Wang Shen-yu,Xie Ying,Zhang Yue,Xie Guang-ru,Zhang Mei-ying,Shi Wen-guang,Guan Nian-bo,Guan Tian-yu,Li Cong-huang,Lu Li-yuan,Zhang Ying,Li Dao-rui,Liu Hao

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Complementary and alternative medicine,General Medicine

Reference31 articles.

1. GLOBOCAN 2012 (IARC) Section of Cancer Information. GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. Available at: http:// globocan.iarc.fr/Default.aspx.

2. Chen WQ, Zheng RS, Baade PD, Zhang SW, Zeng HM, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin 2016;66:115–132.

3. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, et al. SEER cancer statistics review, 1975–2007. National Cancer Institute; 2010. Available at: http://seer. cancer.gov/csr/previous.html.

4. Mountain CF. Revisions in the international staging system for staging lung cancer. Chest 1997;111:1710–1717.

5. National Comprehensive Cancer Network. NCCN clinical practice guideline in oncology: non-small cell Lung cancer vision 2016. Available at: https://www.nccn.org/.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3